Oxymorphone hydrochloride and Weakness - a phase IV clinical study of FDA data

Summary:

No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

No or too few reports are found.

What is Oxymorphone Hydrochloride?

Oxymorphone hydrochloride has active ingredients of oxymorphone hydrochloride. It is used in chronic pain. Currently, eHealthMe is studying from 7,404 Oxymorphone hydrochloride users.

What is Weakness?

Weakness is found to be associated with 5,323 drugs and 6,387 conditions by eHealthMe. Currently, we are studying 555,924 people who have Weakness.

Do you take Oxymorphone hydrochloride and have Weakness?

Check whether Weakness is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Oxymorphone hydrochloride side effects by duration, gender and age:

Oxymorphone hydrochloride side effects (7,404 reports)

Weakness treatments and more:

Weakness (555,924 reports)

All the drugs that are associated with Weakness:

Weakness

All the conditions that are associated with Weakness:

Weakness

How the study uses the data?

The study uses data from the FDA. It is based on oxymorphone hydrochloride (the active ingredients of Oxymorphone hydrochloride) and Oxymorphone hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.